CORTEXA
← Browse
openalexFrontiers in Immunology2026-07-24Cited by 0

Case Report: Papillon–Lefèvre syndrome beyond keratoderma: two index presentations and sibling screening in two families

Hilal Karabağ Çıtlak, Filiz Koç, Gülizar Demir, Gulben Ozgul Postuk, Nurdan Kaykı Aksoy, Oguzhan Demir, Ayberk Türkyılmaz, Alper Han Çebi, ZEYNEP GÖKÇE GAYRETLİ AYDIN, Gul Salci, Nalan Yildiz, Fazıl Orhan

Papillon–Lefèvre syndrome is a rare inherited disorder classically associated with palmoplantar keratoderma and early severe periodontitis, but its clinical presentation may be broader than expected. We report four molecularly confirmed cases from two unrelated families carrying two different homozygous CTSC variants. The first index patient presented with a large iliopsoas abscess as the initial manifestation of the disease, while her monozygotic twin was diagnosed through family screening and had only mild skin and dental findings. In the second family, a 13-year-old boy had recurrent soft-tissue abscesses and palmoplantar lesions whose diagnosis was delayed for many years by a psoriasis-like presentation; his younger brother was later identified through cascade screening with a skin-limited phenotype. These cases show that PLS may present with deep infections, prolonged diagnostic delay, or mild unrecognized disease. Early molecular testing, careful dental and dermatological assessment, multifocal imaging, and systematic family screening are essential for timely diagnosis and appropriate care.

View free PDFSource page

Related papers

openalexFrontiers in Immunology2026-07-23

PD-1 blockade combined with anlotinib and bicalutamide for metastatic primary cutaneous apocrine carcinoma: a case report and literature review

Yuqi Jin, Linglin Fu, X Leng, Yinuo Tan

Background Primary cutaneous apocrine carcinoma (PCAC) is a rare malignant adnexal tumor with substantial diagnostic complexity and no established systemic therapy standard for advanced disease.Evidence for endocrine therapy, targeted therapy, and immune checkpoint inhibitors is…

View free PDFSource page
openalexFrontiers in Immunology2026-07-24

Editorial: Long- and post-COVID syndromes: immune mechanisms and therapeutic strategies

Luca Roncati, Robert Weissert

Long-term coronavirus disease (long-COVID) is an umbrella term that, according to the UK's National Institute for Health and Care Excellence, encompasses the debilitating effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection lasting 4 to 12 weeks and 1…

View free PDFSource page
openalexFrontiers in Immunology2026-07-23

Hepatic granulomas as a manifestation of ANCA-associated vasculitis:a systematic review

T. Ben Achour, Nesrine Ben Hadj Dahman, Maysam Jridi, Fatma Said, I. Ben Ghorbel, I. Naceur, et al.

Background ANCA-associated vasculitides (AAV) — granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA), and microscopic polyangiitis (MPA) — are rare small-vessel autoimmune diseases. Liver involvement in AAV is uncommon and generally manifes…

View free PDFSource page
openalexFrontiers in Immunology2026-07-24

Data-augmented machine learning refines the effective-concentration estimate for eculizumab in complement-mediated diseases

Francisco J. Fernández, Lucía Alfonso‐González, Manuel Praga, Kaare Mikkelsen, M. Cristina Vega

Eculizumab, a humanized monoclonal antibody targeting the complement protein C5, is highly efficient in paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disorder. However, recent reports have…

View free PDFSource page
openalexFrontiers in Immunology2026-07-23

Generation and characterization of an anti ITGB4 monoclonal antibody that blocks Zika virus entry

X D Han, Weiwei Li, Shuqian Yang, Yancun Gong, Jie Shen, Lei Song, et al.

Introduction Zika virus (ZIKV) causes congenital disease and neurological complications, yet no approved vaccines or antivirals are available. Integrin β4 (ITGB4) has been identified as an entry receptor for ZIKV. Methods Recombinant human ITGB4 ectodomain was expressed using a b…

View free PDFSource page
openalexFrontiers in Immunology2026-07-23

Dual-targeting CD73/PD-L1 bifunctional inhibitor: a promising cancer immunotherapy strategy

Jing-Jing Du, Sen Wu, Shiyun Cheng, Xiaobo Zeng, Binbin Cheng

Objectives This work aims to design and characterize a novel bifunctional small molecule that simultaneously targets PD-L1 and CD73 to enhance the therapeutic efficacy of tumor immunotherapy. Methods Multiple methodologies were integrated for compound screening and biological cha…

View free PDFSource page